Metabolomics of Obstructive Sleep Apnea

Completed

Conditions studied: Obstructive Sleep Apnea

In brief

This is an R01 funded project that focuses on the utility of metabolomics as a biomarker for OSA. Aims 1 and 3 leverages banked samples previously collected from subjects with and without OSA at the University of Pennsylvania and University of Iceland. Aim 2 is a prospective study that will collect serum samples from OSA subjects at the University of Pennsylvania and the University of Iceland.

Key facts

Study ID
NCT04572269
Run by
University of Pennsylvania
People needed
388
Starts
2020-09-29
Expected to finish
2025-09-12
Last updated by the study team
2026-05-14

Who can join

Age: 30 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.